Literature DB >> 1470230

Pentylenetetrazol-induced seizures in rats: an ontogenetic study.

L Velisek1, H Kubova, M Pohl, L Stankova, P Mares, R Schickerova.   

Abstract

A quantitative description of motor seizures induced by pentylenetetrazol (PTZ, metrazol) was performed. Seizures were induced by PTZ in doses from 40 to 120 mg/kg s.c. in 477 male albino rats of the Wistar strain 7 to 90 days old. Two patterns of seizures were elicited: minimal, i.e. predominantly clonic seizures of facial and forelimb muscles with preserved righting ability, and major, i.e. generalized tonic-clonic seizures with a loss of righting reflex. Minimal seizures could be reliably elicited since the age of 18 days; the CD50 for these seizures did not significantly differ with age. Major seizures were elicited regularly at all developmental stages studied. Their CD50 did not significantly differ among 7-, 12- and 25-day-old rat pups but the value for 18-day-old rats was smaller and for adult animals larger than these three age groups.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1470230     DOI: 10.1007/bf00169017

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  18 in total

1.  Central nervous system uptake kinetics of pentylenetetrazol in the developing rat.

Authors:  L J Haberer; G M Pollack
Journal:  Biopharm Drug Dispos       Date:  1991 Jan-Feb       Impact factor: 1.627

Review 2.  Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations.

Authors:  W Löscher; D Schmidt
Journal:  Epilepsy Res       Date:  1988 May-Jun       Impact factor: 3.045

3.  The developing animal as a model.

Authors:  A Vernadakis; D M Woodbury
Journal:  Epilepsia       Date:  1969-06       Impact factor: 5.864

4.  Uptake of [14C] pentylenetetrazol by developing rat brain.

Authors:  J J Brink; N Cariglia; D G Stein; L A Galipeau
Journal:  Brain Res       Date:  1970-05-04       Impact factor: 3.252

Review 5.  Progression and generalization of seizure discharge: anatomical and neurochemical substrates.

Authors:  K Gale
Journal:  Epilepsia       Date:  1988       Impact factor: 5.864

6.  Maturation of convulsogenic activity induced by leptazol in the albino rat.

Authors:  M de Casrilevitz; E Engelhardt; C A Esbérard
Journal:  Br J Pharmacol       Date:  1971-05       Impact factor: 8.739

7.  Modification of electroshock and pentylenetetrazol seizure patterns in rats after precollicular transections.

Authors:  R A Browning; D K Nelson
Journal:  Exp Neurol       Date:  1986-09       Impact factor: 5.330

8.  Influence of ethosuximide on metrazol-induced seizures during ontogenesis in rats.

Authors:  P Mares; L Velísek
Journal:  Act Nerv Super (Praha)       Date:  1983-12

9.  Effects of flunarizine on Metrazol-induced seizures in developing rats.

Authors:  M Pohl; P Mares
Journal:  Epilepsy Res       Date:  1987-09       Impact factor: 3.045

Review 10.  Role of the brain-stem reticular formation in tonic-clonic seizures: lesion and pharmacological studies.

Authors:  R A Browning
Journal:  Fed Proc       Date:  1985-05
View more
  17 in total

Review 1.  Pharmacokinetic considerations in the treatment of childhood epilepsy.

Authors:  Jamie T Gilman; Michael Duchowny; Ana E Campo
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

2.  Peptidergic mechanisms of hyperthermia-evoked convulsions in rats in early postnatal ontogenesis.

Authors:  N E Chepurnova; A A Ponomarenko; S A Chepurnov
Journal:  Neurosci Behav Physiol       Date:  2002 Sep-Oct

3.  Ontogenic profile of seizures evoked by the beta-carboline DMCM (methyl-6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate) in rats.

Authors:  Catherine Kulick; Samuel Gutherz; Alexei Kondratyev; Patrick A Forcelli
Journal:  Eur J Pharmacol       Date:  2014-06-23       Impact factor: 4.432

4.  Pharmaco-resistant Neonatal Seizures: Critical Mechanistic Insights from a Chemoconvulsant Model.

Authors:  Shivani C Kharod; Brandon M Carter; Shilpa D Kadam
Journal:  Dev Neurobiol       Date:  2018-08-31       Impact factor: 3.964

5.  Rapamycin has age-, treatment paradigm-, and model-specific anticonvulsant effects and modulates neuropeptide Y expression in rats.

Authors:  Tamar Chachua; Ka-Lai Poon; Mi-Sun Yum; Leigh Nesheiwat; Kara DeSantis; Jana Velíšková; Libor Velíšek
Journal:  Epilepsia       Date:  2012-09-27       Impact factor: 5.864

6.  Anticonvulsant action of 2-chloroadenosine against pentetrazol-induced seizures in immature rats is due to activation of A1 adenosine receptors.

Authors:  P Mareš
Journal:  J Neural Transm (Vienna)       Date:  2010-08-31       Impact factor: 3.575

Review 7.  Developmental seizure models.

Authors:  L Velísek; J Velísková; S L Moshé
Journal:  Ital J Neurol Sci       Date:  1995 Feb-Mar

8.  Glutamate receptor 1 phosphorylation at serine 831 and 845 modulates seizure susceptibility and hippocampal hyperexcitability after early life seizures.

Authors:  Sanjay N Rakhade; Erin F Fitzgerald; Peter M Klein; Chengwen Zhou; Hongyu Sun; Richard L Huganir; Richard L Hunganir; Frances E Jensen
Journal:  J Neurosci       Date:  2012-12-05       Impact factor: 6.167

9.  Profile of anticonvulsant action of levetiracetam, tiagabine and phenobarbital against seizures evoked by DMCM (methyl-6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate) in neonatal rats.

Authors:  Catherine V Kulick; Samuel B Gutherz; Veronica C Beck; Natalia Medvedeva; Colin Soper; Patrick A Forcelli
Journal:  Eur J Pharmacol       Date:  2014-09-22       Impact factor: 4.432

10.  Anticonvulsant Action of GluN2A-Preferring Antagonist PEAQX in Developing Rats.

Authors:  Pavel Mares; Grygoriy Tsenov; Hana Kubova
Journal:  Pharmaceutics       Date:  2021-03-19       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.